Effect of albumine- furosemide in oligouric patients
Not Applicable
- Conditions
- AKI.Acute renal failure, unspecified
- Registration Number
- IRCT201412132582N12
- Lead Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
patients admitted to the intensive care unit; oligouria; serum albumin<3g/dl; generalized edema; requiring the use of furosemide to increase urine output
Exclusion criteria: serum albumin>3g/dl; nonoligouric acute renal failure; balance of fluid loaded to the patient and no need for greater diuresis by the physician; receiving diuretics in the past 48 hours; hemodynamically unstable patients with vasopressor dependence; pregnancy; ESRD patients with anuria, cirrhosis, nephrotic syndrome, cardiogenic shock and CRF
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary furosemide. Timepoint: 24-hour urine sample will be collected every 2 hours until 12 hours and then one sample for the next 12 hours. Method of measurement: HPLC.
- Secondary Outcome Measures
Name Time Method rinary Na. Timepoint: Urine sampling will be at 8-10,10-12,12-14, 14-16,16-18 and 18-20 o,clock and then 20 till 8 in the next day,s morning. Method of measurement: HPLC.